Conquering Diseases

Study Of An Investigational Drug For Ovarian Or Peritoneal Cancer


Seeking women diagnosed with low-grade serous cancer of the ovary or peritoneum for a study of an investigational drug to reduce the risk of the cancer progressing or returning.


Participants in this study will be randomly assigned to get either the usual chemotherapy drugs to treat their cancer and the investigational drug or only the investigational drug without chemotherapy unless the cancer progresses or returns.

What we're hoping for

We are studying whether use of an investigational drug by itself or in combination with the usual treatment for low-grade serous ovarian or peritoneal cancer reduces the risk of the cancer growing or spreading.

Additional Information Identifier: NCT04095364

 Principal Investigator

Susan  Zweizig, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office



UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655